The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
Open accessAbstract
Proteinases like thrombin, trypsin and tissue kallikreins are now known to regulate cell signaling by cleaving and activating a novel family of G‐protein‐coupled proteinase‐activated receptors (PARs 1–4) via exposure of a tethered receptor‐triggering ligand. On their own, short synthetic PAR‐selective PAR‐activating peptides (PAR‐APs) mimicking the tethered ligand sequences can activate PARs 1, 2 and 4 and cause physiological responses both in vitro and in vivo.Using the PAR‐APs as sentinel probes in vivo, it has been found that PAR activation can affect the vascular, renal, respiratory, gastrointestinal, musculoskeletal and nervous systems (both central and peripheral nervous system) and can promote cancer metastasis and invasion. In general, responses triggered by PARs 1, 2 and 4 are in keeping with an innate immune inflammatory response, ranging from vasodilatation to intestinal inflammation, increased cytokine production and increased or decreased nociception. Further, PARs have been implicated in a number of disease states, including cancer and inflammation of the cardiovascular, respiratory, musculoskeletal, gastrointestinal and nervous systems. In addition to activating PARs, proteinases can cause hormone‐like effects by other signalling mechanisms, like growth factor receptor activation, that may be as important as the activation of PARs. We, therefore, propose that the PARs themselves, their activating serine proteinases and their associated signalling pathways can be considered as attractive targets for therapeutic drug development. Thus, proteinases in general must now be considered as ‘hormone‐like’ messengers that can signal either via PARs or other mechanisms. British Journal of Pharmacology(2008)153, S263–S282; doi:10.1038/sj.bjp.0707507; published online 3 December 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–261 of 261
Al‐Ani, B., Saifeddine, M., Wijesuriya, S. J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.702 · Cited by 69
Plasmin-platelet interaction involves cleavage of functional thrombin receptor
Kimura, M., Andersen, T. T., Fenton, J. W., Bahou, W. F., & Aviv, A. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.1.c54 · Cited by 64
Robin, J., Kharbanda, R. K., McLean, P. G., Campbell, R. O., & Vallance, P. J. (2003) · Circulation · doi:10.1161/01.cir.0000050620.37260.75 · Cited by 63
Macfarlane, S. R., Sloss, C. M., Cameron, P., Kanke, T., McKenzie, R. C., & Plevin, R. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706204 · Cited by 62
Hansen, K. K., Saifeddine, M., & Hollenberg, M. D. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01870.x · Cited by 62
Self-citationShiosaka, S., & Yoshida, S. (2000) · Neuroscience Research · doi:10.1016/s0168-0102(00)00115-2 · Cited by 62
Cuffe, J. E., Bertog, M., Velázquez‐Rocha, S., Déry, O., Bunnett, N. W., & Korbmacher, C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013159 · Cited by 61
Yang, L., Bae, J., Manithody, C., & Rezaie, A. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702131200 · Cited by 61
Decreases in protease nexins in Alzheimer's disease brain
Choi, B.-T., Kim, R. C., Vaughan, P. J., Lau, A., Nostrand, W. E. V., Cotman, C. W., & Cunningham, D. D. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00060-r · Cited by 61
Evidence for the presence of functional protease activated receptor 4 (PAR 4 ) in the rat colon
Mulè, F., Pizzuti, R., Capparelli, A., & Vergnolle, N. (2004) · Gut · doi:10.1136/gut.2003.021899 · Cited by 60
Naldini, A., Carney, D. H., Pucci, A., Pasquali, A., & Carraro, F. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00113-6 · Cited by 59
Hollenberg, M. D., Saifeddine, M., Al‐Ani, B., et al. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-090 · Cited by 59
Self-citationShpacovitch, V. M., Varga, G., Strey, A., Gunzer, M., Mooren, F. C., Buddenkotte, J., Vergnolle, N., Sommerhoff, C. P., Grabbe, S., Gerke, V., et al. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0503221 · Cited by 59
Self-citationCénac, N., Cellars, L., Steinhoff, M. S., Andrade‐Gordon, P., Hollenberg, M. D., Wallace, J. L., Fiorucci, S., & Vergnolle, N. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000177506.71784.bd · Cited by 58
Self-citationGui, Y., Loutzenhiser, R., & Hollenberg, M. D. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00396.2002 · Cited by 58
Self-citationVanhauwe, J. F. M., Thomas, T. O., Minshall, R. D., Tiruppathì, C., Li, A., Gilchrist, A., Yoon, E.-J., Malik, A. B., & Hamm, H. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204477200 · Cited by 56
Bretschneider, E., Kaufmann, R., Braun, M. A., et al. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703947 · Cited by 55
Hamilton, J. R., Moffatt, J. D., Frauman, A. G., et al. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200107000-00012 · Cited by 55
Cumashi, A., Ansuini, H., Celli, N., et al. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615617 · Cited by 54
Neural Thrombin and Protease Nexin I Kinetics After Murine Peripheral Nerve Injury
Smirnova, I. V., Jianxin, Y., Citron, B. A., Ratzlaff, K. T., Gregory, E. J., Akaaboune, M., & Festoff, B. W. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052188.x · Cited by 53
Chow, J. M., Moffatt, J. D., & Cocks, T. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703738 · Cited by 52
Spanbroek, R., Lötzer, K., Habenicht, A. J. R., et al. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0203 · Cited by 51
Dual effect mediated by protease‐activated receptors on the mechanical activity of rat colon
Mulè, F., Baffi, M. C., & Cerra, M. C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704746 · Cited by 51
Vouret‐Craviari, V., Grall, D., & Obberghen‐Schilling, E. V. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00238.x · Cited by 51
Factor Xa induces mitogenesis of coronary artery smooth muscle cell via activation of PAR‐2
Koo, B.-H., Chung, K.-H., Hwang, K.-C., et al. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02948-4 · Cited by 50
Bretschneider, E., Kaufmann, R., Braun, M., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702509 · Cited by 50
Buresi, M. C., Buret, A. G., Hollenberg, M. D., & MacNaughton, W. K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0039com · Cited by 49
Self-citationTerayama, R., Bandô, Y., Takahashi, T., & Yoshida, S. (2004) · Glia · doi:10.1002/glia.20058 · Cited by 48
Tanaka, M., Arai, H., Liu, N., et al. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00317.x · Cited by 47
A protective role of protease-activated receptor 1 in rat gastric mucosa
Kawabata, A., Nishikawa, H., Saitoh, H., Nakaya, Y., Hiramatsu, K., Kubo, S., Nishida, M., Kawao, N., Kuroda, R., Sekiguchi, F., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.071 · Cited by 46
Holinstat, M. A., Voss, B., Bilodeau, M. L., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.029371 · Cited by 45
Seatter, M. J., Drummond, R. M., Kanke, T., et al. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00095-0 · Cited by 44
Maryanoff, B. E., Zhang, H., Andrade‐Gordon, P., et al. (2003) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016033356724 · Cited by 41
Minn, A., Schubert, M., Neiss, W. F., & Müller‐Hill, B. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<338::aid-glia3>3.0.co;2-# · Cited by 40
Vesey, D. A., Hooper, J. D., Gobe, G. C., & Johnson, D. W. (2007) · Nephrology · doi:10.1111/j.1440-1797.2006.00746.x · Cited by 38
Wang, Y., Luo, W., Wartmann, T., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04105.x · Cited by 38
Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
Nantermet, P. G., Barrow, J. C., Lundell, G. F., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00745-4 · Cited by 37
Playford, R. J., Hanby, A. M., Patel, K. T., & Calam, J. (1995) · Europe PMC (PubMed Central) · Cited by 37
Ramachandran, R., Sadofsky, L. R., Xiao, Y., et al. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00226.2006 · Cited by 35
Self-citationProteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3
Villegas-Méndez, A., Montes, R., Ambrose, L. R., Warrens, A. Ν., Laffan, M., & Lane, D. A. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02480.x · Cited by 34
Proteinase-activated receptors (PARs)—the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1
Kaufmann, R., Schulze, B., Krause, G., et al. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.032 · Cited by 32
Seymour, M. L., Zaidi, N. F., Hollenberg, M. D., & MacNaughton, W. K. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00126.2002 · Cited by 32
Self-citationRamachandran, R., Morice, A. H., & Compton, S. J. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0362oc · Cited by 31
Self-citationChaikof, E. L., Caban, R., Yan, C., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7431 · Cited by 30
Kanthou, C., Kanse, S. M., Kakkar, V. V., & Benzakour, O. (1996) · Cellular Signalling · doi:10.1016/0898-6568(95)02018-7 · Cited by 29
A role for proteinase-activated receptor–1 in inflammatory bowel diseases
Vergnolle, N., Cellars, L., Mencarelli, A., Rizzo, G., Swaminathan, S., Beck, P. A., Steinhoff, M. S., Andrade‐Gordon, P., Bunnett, N. W., Hollenberg, M. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421689 · Cited by 28
Self-citationInvolvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis
Terayama, R., Bandô, Y., Yamada, M., & Yoshida, S. (2005) · Glia · doi:10.1002/glia.20226 · Cited by 27
PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions
Trottier, G., Hollenberg, M. D., Wang, X., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2001 · Cited by 27
Self-citationThe Enteric Nervous System in Inflammation and Pain: The Role of Proteinase-Activated Receptors
Vergnolle, N. (2003) · Canadian Journal of Gastroenterology · doi:10.1155/2003/683731 · Cited by 26
Kawabata, A., Kinoshita, M., Kuroda, R., & Kakehi, K. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03641.x · Cited by 26
Hamilton, J. R., Moffatt, J. D., Tatoulis, J., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704714 · Cited by 26
Shooting for PARs in lung diseases
Moffatt, J. D. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.01.012 · Cited by 25
Kaufmann, R., JUNKER, U., Nuske, K., Westermann, M., Henklein, P., Scheele, J., & Junker, K. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.1.177 · Cited by 25
Plasmin Deficiency in Alzheimer’s Disease Brains: Causal or Casual?
Dotti, C. G., Galván, C. A., & Ledesma, M. D. (2004) · Neurodegenerative Diseases · doi:10.1159/000080987 · Cited by 25
Olianas, M. C., Dedoni, S., & Onali, P. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.059 · Cited by 24
Bilodeau, M. L., & Hamm, H. E. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121830 · Cited by 23
Fujiwara, M., Jin, E., Ghazizadeh, M., & Kawanami, O. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6592.2005 · Cited by 22
Seymour, M. L., Binion, D. G., Compton, S. J., Hollenberg, M. D., & MacNaughton, W. K. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-046 · Cited by 21
Self-citationProtease-activated receptors and inflammatory hyperalgesia
Vergnolle, N. (2005) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762005000900029 · Cited by 16
Mast cell tryptase and its role in tissue remodelling
Cairns (1998) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1998.00467.x · Cited by 13
Proteinase-activated Receptors
Cunningham, M., & Plevin, R. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_122 · Cited by 12
Cited by
Epidermal Barrier Dysfunction in Atopic Dermatitis
Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., MacGowan, A. L., Tazi-Ahnini, R., & Ward, S. J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.133 · Cited by 765
Structure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Self-citationGuo, Y., Nguyen, K.-A., & Potempa, J. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00377.x · Cited by 365
Kouzaki, H., O'Grady, S. M., Lawrence, C. B., & Kita, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900904 · Cited by 358
Targeting proteinase-activated receptors: therapeutic potential and challenges
Ramachandran, R., Noorbakhsh, F., DeFea, K., & Hollenberg, M. D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3615 · Cited by 312
Self-citation
Metadata
- Authors
- Ramachandran, R., & Hollenberg, M. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-03
- Volume
- 153
- Issue
- S1
- Pages
- S263-82
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1889671843
- Cited by
- 305
- References
- 261
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.